Sherry Aulin
Chief Financial Officer, Xenon Pharmaceuticals.
Companies
- Xenon PharmaceuticalsChief financial officer Jun 3, 2021 to Dec 19, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Xenon Pharmaceuticals XENE0 shares2Dec 18, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 18, 2024Sold 11,510 shares at $41.19 of Xenon Pharmaceuticals2
- Dec 18, 2024Shares withheld for tax 4,490 shares at $41.28 of Xenon Pharmaceuticals2
- Dec 18, 2024Exercised options 16,000 shares at $11.58 of Xenon Pharmaceuticals2
- Dec 18, 2024Sold 7,199 shares at $41.23 of Xenon Pharmaceuticals2
- Dec 18, 2024Shares withheld for tax 2,135 shares at $41.28 of Xenon Pharmaceuticals2
- Dec 18, 2024Exercised options 9,334 shares at $9.44 of Xenon Pharmaceuticals2
- Sep 2, 2022Sold 15,355 shares at $39.57 of Xenon Pharmaceuticals3
- Sep 2, 2022Shares withheld for tax 3,293 shares at $39.53 of Xenon Pharmaceuticals3
- Sep 2, 2022Exercised options 6,511 shares at $4.75 of Xenon Pharmaceuticals3
- Sep 2, 2022Exercised options 2,292 shares at $3.10 of Xenon Pharmaceuticals3
- Sep 2, 2022Exercised options 813 shares at $8.40 of Xenon Pharmaceuticals3
- Sep 2, 2022Exercised options 32 shares at $7.49 of Xenon Pharmaceuticals3
- Sep 2, 2022Exercised options 9,000 shares at $9.44 of Xenon Pharmaceuticals3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Sep 7, 2022